United Laboratories International Holdings Ltd ULIHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.83
- Day Range
- $0.89–0.89
- 52-Week Range
- $0.71–0.89
- Bid/Ask
- $1.10 / $1.34
- Market Cap
- $1.62 Bil
- Volume/Avg
- 100 / 100
Key Statistics
- Price/Earnings (Normalized)
- 5.12
- Price/Sales
- 0.86
- Dividend Yield (Trailing)
- 4.07%
- Dividend Yield (Forward)
- 4.07%
- Total Yield
- 4.08%
Company Profile
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 15,000
- Website
- http://www.tul.com.cn
Comparables
Valuation
|
Metric
|
ULIHF
|
02877
|
03692
|
|---|---|---|---|
Price/Earnings (Normalized) | 5.12 | 7.13 | 29.01 |
Price/Book Value | 1.02 | 0.99 | 3.26 |
Price/Sales | 0.86 | 1.41 | 8.43 |
Price/Cash Flow | 4.04 | 6.37 | 31.71 |
Price/Earnings
ULIHF
02877
03692
Financial Strength
|
Metric
|
ULIHF
|
02877
|
03692
|
|---|---|---|---|
Quick Ratio | 1.46 | 3.20 | 3.66 |
Current Ratio | 1.87 | 3.58 | 3.74 |
Interest Coverage | 28.40 | 2,380.41 | 41.01 |
Quick Ratio
ULIHF
02877
03692
Profitability
|
Metric
|
ULIHF
|
02877
|
03692
|
|---|---|---|---|
Return on Assets (Normalized) | 11.75% | 10.83% | 8.91% |
Return on Equity (Normalized) | 20.68% | 13.16% | 11.95% |
Return on Invested Capital (Normalized) | 17.38% | 12.66% | 8.47% |
Return on Assets
ULIHF
02877
03692
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ctclqpqk | Fzjgnd | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Yplxshjt | Cld | $68.9 Bil | |
HLN
| Haleon PLC ADR | Hlrdkxm | Lhfr | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Tbppszy | Jbd | $14.7 Bil | |
VTRS
| Viatris Inc | Tqstznf | Pxzds | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rnkmlylx | Zvrnb | $11.9 Bil | |
CTLT
| Catalent Inc | Lrffflx | Xkcmf | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Kkzlzlvjs | Vddg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Wslwpwmts | Ldvg | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Zrxfpmqm | Vtxbtw | $3.5 Bil |